Longevity 2020

Defining biological aging

Longevity TV

Towards a consensus definition of biological aging

Phil Newman - April 27, 2020 0

Attila Csordas, Founder & Director, AgeCurve Ltd.

Longevity TV

Reversal of several aging pathways & diseases

Phil Newman - April 27, 2020 0

George Church, Founding Core Faculty & Lead, Synthetic Biology, Wyss Institute at Harvard University.

Longevity TV

Leveraging aging science (geroscience) to improve older adults’ immune health

Phil Newman - April 27, 2020 0

Nir Barzilai, Director, Institute for Aging Research.

Longevity TV

Connections & differences between different hallmark processes

Phil Newman - April 27, 2020 0

Lynne Cox, Associate Professor in Biochemistry, University of Oxford.

Rejuvenation therapies

Longevity TV

The divide-and-conquer nature of rejuvenation can be an asset, not a challenge

Phil Newman - April 28, 2020 0

Aubrey de Grey, Founder and CEO, SENS Foundation.

Longevity 2020

The use of TORC1 inhibitors to improve immune function in the elderly

Phil Newman - April 28, 2020 0

Joan Mannick, Chief Medical Officer, resTORbio

Longevity TV

How do we show in humans that a drug targets aging?

Phil Newman - April 28, 2020 0

Nir Barzilai, Director, Institute for Aging Research

Longevity TV

Geroprotectors: time to change the way we treat older people?

Phil Newman - April 28, 2020 0

Ilaria Bellantuono, Professor in Musculoskeletal Ageing, Co-Director, The Healthy Lifespan Institute, Department of Oncology and Metabolism

AI & Longevity

Longevity TV

Extending healthspan with NaNot nano-extractors

Phil Newman - April 29, 2020 0

Lou Hawthorne, CEO, NaNotics

Longevity TV

Interview with Margaretta Colangelo

Phil Newman - April 29, 2020 0

Margaretta Colangelo, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics

Longevity TV

Applying AI approaches to diverse aging-related problems

Phil Newman - April 29, 2020 0

Alexander Zhavoronkov, Chief Executive Officer, Insilico Medicine, Inc

Longevity TV

Margaretta Colangelo in conversation with Richard Siow, John Shepherd, and Alexander Zhavoronkov

Phil Newman - April 29, 2020 0

Margaretta Colangelo, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics

Longevity investing

Longevity TV

The Big Picture: Covid-19 and Longevity investing

Phil Newman - April 30, 2020 0

Jim Mellon, Chairman and Founder, Burnbrae Group

Longevity TV

The view from the valley

Phil Newman - April 30, 2020 0

Kate Batz, Managing Partner, Longevity Capital and Director of Strategy at Deep Knowledge Ventures and Aging Analytics Agency.

Longevity TV

Accelerating agetech

Phil Newman - April 30, 2020 0

Lorraine Morley, UK Lead / Advisor, AgeTech Accelerator

Longevity TV

The Juvenescence business model and future of anti-aging

Phil Newman - April 30, 2020 0

Greg Bailey, CEO, Juvenescence

Longevity start now

Longevity TV

Longevity: Start now … Introduction

Phil Newman - May 1, 2020 0

Johnny Adams, CEO / Executive Director, Aging Intervention Foundation; Executive Director, Gerontology Research Group

Longevity TV

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Phil Newman - May 1, 2020 0

Reason, Co-founder and CEO, Repair Biotechnologies & Fight Aging!

Longevity TV

Rejuvant – starting Longevity now

Phil Newman - May 1, 2020 0

Tom Weldon, Founder, Executive Chairman, Acting CEO, Ponce De Leon Health

Longevity TV

How can BioViva address the here and now?

Phil Newman - May 1, 2020 0

Liz Parrish, CEO, BioViva Sciences

Longevity 2020

Latest articles